Brands
Spectru™
Spectru™ empowers early drug development researchers by offering a selection of highly validated antibody panels.
Spectru™ Solution
Platform Benefits
Spectru™ was established in 2013 as our signature brand of flow cytometry products. The name is a coined term that abbreviates the word “spectrum”, referring to the visual properties of flow cytometry testing, in a way that reveals the word “true” which comments on the clarity of finding results. Also sounding like the word “specter,” Spectru™ embodies the idea of revealing information that was initially invisible.
Spectru™ empowers early drug development laboratories by offering a selection of highly validated antibody panels. Exceptional product stability allows researchers to perform longitudinal studies without the need to revalidate new lots. Additionally, Spectru™ flow cytometry panels provide the reproducibility and accuracy needed to achieve superior results at a fraction of the cost.
Key Features
- Performance data in the context of applicable compounds
- Superb stability of ≥ 24 months from date of manufacture
- Quality you can trust with up to 50% cost savings
Shop Spectru™ Products
InhibiScreen Kinase Inhibitor Assay
Our InhibiScreen Kinase Inhibitor Assay offers an easy, fast and reliable solution for analyzing basophil activation status via flow cytometry. With the inclusion of two controls, the assay can provide insight into drug potency and therapeutic efficacy of PI3K, BTK and SYK inhibitors in development.
Benefits
Results
Results in 30 minutes.
Reproducible Data
Reproducible data when samples are acquired at 0, 24 and 96 hours post-staining.
Product Specifications
| Catalog #: | 81-INHBAT-100 |
| Species: | Human |
| Excitation Laser: | Blue |
| Size: | 100 Tests |
| Sample Type: | Whole Blood |
| Sample Size: | 100 µL |
A Validated Research Tool to Measure the Efficacy of Kinase Inhibitors in Development
Whole blood collected in EDTA was treated with increasing doses of the PI3K inhibitor, CAL-101. As the dose increased, CD63 expression decreased, exemplifying the suppression of PI3K-mediated basophil activation.
Featured Posts
view all
InhibiScreen: A Kinase Inhibitor Screening Tool
Learn More
Improving the Kinase Inhibitor Development Process
Learn MoreTechnical Literature
Related Resources
Brands
Our commitment to support the advancement of research & clinical outcomes led us to develop our STELLUX® Chemiluminescence and Spectru™ Flow Cytometry brands.
STELLUX® was introduced to the market in April 2013 as our chemiluminescent assay platform. The name is a term that merges the Latin words for “star” and “light” to describe the enzyme activated chemical reaction that occurs through chemiluminescence, literally bringing test results to light out of darkness.
Learn More
Spectru™ was established in 2013 as our signature brand of flow cytometry products. The name is a coined term that abbreviates the word “spectrum”, referring to the visual properties of flow cytometry testing, in a way that reveals the word “true” which comments on the clarity of finding results. Also sounding like the word “specter,” Spectru™ embodies the idea of revealing information that was initially invisible.
Learn More